For well over 20 years the practice of Faecal Microbiota Transplant (FMT) has been shown to have significant benefit to patients suffering from certain chronic gut-related illnesses. Particularly effective in the treatment of Clostridium difficile (C. diff), the therapy is now being investigated for a wider range of conditions, and exciting progress is being made every day.